Indeed, resveratrol treatment of hypertensive rodents reduced systemic levels of HNE, rescued arterial LKB1-AMPK-eNOS activity and attenuated high blood pressure [95], suggesting that resveratrol can improve reactive oxygen species-mediated impaired AMPK-eNOS signaling. Here, NOS3 is linked to hypertensive disorder.